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Joint replacements may fail due to infection, dislocation, peri-prosthetic fracture and loosening. Between 0.4 and
4% of joint replacements are known to be complicated by infection and aseptic loosening 2–18%. Differentiating
between infection and aseptic loosening has an important bearing on the ongoing strategy for antimicrobial therapy
and surgical intervention, but distinguishing one from the other can be difficult and will often require a battery
of clinical and biochemical tests including the use of varying radiological modalities to accurately identify whether
problematic joints are infected or aseptically loose. Prompt diagnosis is important due to the development of a biofilm
on the surface of the infected prosthesis, which makes treatment difficult. There is no consensus among experts on the
ideal imaging technique nor the methodology for image interpretation, but there is an increasing trend to apply hybrid
imaging in the investigation of painful joint prosthesis and recent attempts have been made using PET-CT to identify
aseptic loosening and infection with 18F-fluorodeoxyglucose (FDG) and sodium fluoride 18F-Na. The aim of this paper is
to evaluate the role of 18F-NaF sodium fluoride (18F-NaF) positron emission tomography (PET) in distinguishing
between septic and aseptic failure in hip and knee replacements, in addition to evaluating the feasibility of using
multi-sequential 18F-NaF PET-CT for the assessment of painful lower limb prostheses.
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Joint replacement is the surgical intervention of choice
for end-stage arthritis. A small but significant proportion
of these patients with joint prostheses go on to suffer
implant failure. Causes for failure include infection, dis-
location, peri-prosthetic fracture and loosening.
It is estimated that between 0.4 and 4% of joint replace-
ments are known to be complicated by infection [1] and
aseptic loosening 2–18% [2]. Although differentiating be-
tween infection and aseptic loosening has an important
bearing on the ongoing strategy for antimicrobial therapy
and surgical intervention [3], distinguishing one from the
other can be difficult and will often require a battery of
clinical and biochemical tests including the use of varying
radiological modalities to accurately identify whether
problematic joints are infected or aseptically loose.
Prompt diagnosis is important due to the development of* Correspondence: adesanya@doctors.org.uk
1University of Warwick, Coventry CV4 7AL, England, UK
Full list of author information is available at the end of the article
© 2015 Adesanya et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.a biofilm on the surface of the infected prosthesis, which
makes treatment difficult [4].
There is currently no consensus among experts on the
ideal imaging technique nor the methodology for image
interpretation [5]. Current imaging investigations used
in problematic prosthetic joints include serial radio-
graphs, contrast arthrography, ultrasound, magnetic res-
onance imaging (MRI), computed tomography (CT) and
conventional Nuclear Medicine studies [6], supported by
blood tests such as erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP) and the white cell count
[7]. In the absence of other inflammatory conditions, the
white cell count is least useful [8], while CRP is most
useful from the third week after joint replacement sur-
gery, but ESR may take 3 to 12 months to return to nor-
mal levels [7,8].
CT and MRI imaging for prostheses produce high ana-
tomical detail, but metal-related artefacts can reduce
image quality and sensitivity. Ultrasound can detect soft-
tissue collections; and help guide joint aspiration andral. This is an Open Access article distributed under the terms of the Creative
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niques yield little anatomical detail and are sensitive but
non-specific for diagnosing loosening and infection.
Thus, there is an increasing trend to apply hybrid im-
aging in the investigation of painful joint prosthesis,
often employing SPECT-CT, which combines the high
resolution of CT and the functional sensitivity of Single
Photon Emission Tomography (SPECT) [9]. Recent at-
tempts have been made using PET-CT to identify aseptic
loosening and infection with 18F-fluorodeoxyglucose
(FDG) and sodium fluoride 18F-NaF [10,11]. Sodium
fluoride metabolism in bone is reliant on the rate of
blood flow, which is the rate-limiting step. Most of the
sodium fluoride delivered to the bone is retained after a
single pass of blood [12] making it an excellent radio-
pharmaceutical to assess subtle changes in bone hyper-
aemia and turnover [13]. The first pass rate varies
among different bone types [12], with the degree NaF
uptake in bone marrow being negligible when compared
with the bony cortex levels [12]. 18F-NaF bone uptake is
dependent on the exchange of fluoride ions with hy-
droxyl ions in hydroxyapatite crystal to form fluoroapa-
tite [13]. 18F-NaF is freely diffusible across membranes
and 1 h after injection, only 10% of 18F-NaF remains in
the plasma. 18F-NaF is rapidly cleared from plasma and
excreted by the renal system following glomerular filtra-
tion and tubular secretion [12,14].
The aim of this paper is to evaluate the role of 18F-
NaF sodium fluoride (18F-NaF) positron emission tom-
ography (PET) in distinguishing between septic and
aseptic failure in hip and knee replacements, in addition
to evaluating the feasibility of using multi-sequential




A systematic review of the literature was undertaken
according to the methods described in the Cochrane
Handbook for Systematic Review of Interventions.
Research question
What is the evidence for use of sodium fluoride PET-CT
in differentiating between septic and aseptic failure of
hip and knee replacements?
Inclusion criteria
Human prospective studies that reported data on so-
dium fluoride in joint prosthesis imaging to diagnose
loosening and/or infection.
Exclusion criteria
Studies were excluded where other isotopes other than so-
dium fluoride were used. Studies were limited to Englishlanguage and filters for human studies and clinical trials
were applied.
Search strategy
Studies were identified using MeSH terms and keywords
in MEDLINE, EMBASE, Cochrane and Dynamed. About
133 were excluded at title and abstract; 1 was excluded
at full paper review. No paper was added after review of
the references.
PubMed MESH search terms -(((((((((infection) OR sep-
sis) OR loosening) OR aseptic loosening) OR osteolysis))
AND ((((prosthesis) OR joint replacement) OR knee re-
placement) OR hip replacement)) AND ((((((sodium fluor-
ide) OR fluoride) OR fluorine) OR NaF) NOT FDG) NOT
fluorodeoxyglucose))) NOT dental.
Two authors checked all data used in the analysis.
When disagreements arose, these were resolved by
consensus.
Initially, title and abstracts were reviewed. Potentially
relevant papers were reviewed in their entirety. The ref-
erences cited by each potentially relevant paper were
scrutinised in order to locate additional potentially rele-
vant papers.
Statistics
The summative weighted sensitivities and specificities
were calculated from the data extracted.
Results
Following data extraction, three studies were selected
which satisfied the required characteristics. Data were
extracted from each study and are summarised in
Table 1.
The review identified three prospective studies [15-17]
that met our search criteria. The selected studies consist
of a total number of 94 patients which looked at 110
joints. There were 96 hips and 14 knees, of which 35
were asymptomatic and 65 joints were symptomatic.
Only one study differentiated aseptic loosening from in-
fection [15]. Minimal time from surgery varied from 3
months to just over 12 months. Twenty-two patients
were followed up surgically, while the remaining patients
were followed up clinically for periods varying from 6 to
12 months. A weighted average of sensitivity and specifi-
city of the different studies was determined from the
three studies. The sensitivity of 18F-NaF-PET in identify-
ing prosthesis infections was found to be 97.04%; this
was calculated from the weighted average sensitivity
from the three different studies. The weighted specifi-
city, PPV, NPV and accuracy are 88.11, 84.68, 98.82 and
87.33%, respectively. Of the three studies, Sterner et al
[16] reported the lowest specificity. These results are re-
ported in Table 2.
Table 1 Summary of included studies


























31 N/A 31 0 13 Yes 18 3 to 9
months
12 months 5 No
2007 Sterner et al. 14 9/6 0 14 14 No 0 1.1 years 6 months 6 No
2011 Kobayashi N
et al.
49 N/A 65 0 38 Yes 27 1 year 12 months 11 Yes
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nised by Monte Blau and team in 1962 [18,19], but Hans
Creutzig in Hannover was the first to demonstrate the
importance of 18F-NaF-PET in joint prosthesis infection
in 1976 with 31 total hip replacements [17]. He also
mapped the comparable normal peri-prosthetic pattern
of both Tc99m HEDP (hydroxyethylidenediphosphonate)
and 18F-NaF uptake in the post-surgical period from 3
to 12 months using uptake ratio in both symptomatic
and asymptomatic prostheses. The ratios were found to
decline rapidly (Figures 1 and 2) and reach a nadir at 6–
9 months following surgery with more rapid decline
demonstrated in the femoral component [17]. Interest-
ingly, departures from this normal pattern of decline
preceded the development of symptoms in patients with
bone and soft tissue infections [17]. In this study, the
distinction between aseptic loosening and infection was
unclear. Images were acquired 3 h after the injection of
148 MBq of 18F sodium fluoride. Relatively poor quality
images from using coincidence imaging and a 5″-recti-
linear scanner may have accounted for inability to distin-
guish soft tissue infection from bone infection [17]. The
3-h uptake period would also have been detrimental be-
cause early high target-to-background ratios in result in
peak bone uptake levels around 45–60 min after radio-
isotope injection [20]. At 60 min after radioisotope injec-
tion, only 10% of F18- fluoride remains in the plasma
due to negligible plasma protein binding, rapid blood
and renal clearance, and high bone uptake [20].
Thomas Sterner performed the only prospective study
with the use of 18F-NaF in imaging knee prosthesis, but
no attempt was made to differentiate aseptic loosening
from infection [16]. Fourteen symptomatic knee pros-
theses were examined and no control group was
employed. Of these 14 patients, 6 underwent surgery forTable 2 Results from the included studies
Authors Patients (joints) TP TN FP FN
Creutzig H. et al. 31 (31) 13 14 4 0
Sterner et al. 14 (14) 5 5 4 0
Kobayashi N et al. 49 (65) 36 23 6 2confirmation of the imaging findings and the other 8
were followed up clinically for 6 months. The relatively
low specificity in this study may have arisen from several
factors including the fact that this the study included
only knees, the sample size was relatively small and finally
that even intermediate levels of peri-prosthetic uptake
were regarded as positive for aseptic loosening or infection
[16]. He also regarded the scan as abnormal if (a) there
was more uptake in the prosthesis/bone interface than in
normal/bone/soft tissue or contralateral asymptomatic
prosthesis, (b) the increased uptake included half the
bone/metal interface in the femoral component or (c) if
the tibial stem in the tibial component was involved.
Furthermore, they discovered that the use of semi-
quantitative analysis with standardised uptake values
(SUVs) yielded no added value [16]. Image quality in
this study was bound to be better because the authors
employed an ECAT-Exact HR+ (Siemens Medical Sys-
tems) PET scanner 1 and 60 min after the injection of
350 MBq of18F fluoride [16].
In 2011, Naomi Kobayashi et al. published a prospect-
ive study of 18F-NaF PET in 65 hip prostheses; to date,
this has been the only prospective trial which differenti-
ated aseptic loosening from sepsis [15]. Images were ac-
quired 40 min after injection of 185 MBq of 18F fluoride
using a SET 2400W device (Shimadzu, Kyoto, Japan).
She was able to distinguish between normal, aseptic
loosening and infected prostheses. The first method in-
volved measuring the degree of 18F fluoride uptake in
peri-prosthetic tissues (SUVmax). Average values for the
normal, aseptic and septic loosening prostheses were es-
timated to be 4.9 ± 2.5, 8.1 ± 2.9 and 10.5 ± 3.4, respect-
ively [15]. When a threshold SUVmax of 6.9 is applied
for diagnosis of infection, the test had a sensitivity and
specificity of 81 and 80%, respectively [15]. Furthermore,Sensitivity Specificity PPV NPV Accuracy
100 0.78 0.76 100 0.87
100 0.56 0.56 100 0.71
0.95 0.88 0.95 0.98 0.91
Figure 2 Uptake ratios in patients without complications over
the thigh. Graphical representation of normal HEDP uptake levels in
the acetabular (Figure 1) and femoral components (Figure 2). NaF
uptake levels are said to be similar (14). Reproduced from Creutzig
H. Bone imaging after total replacement arthroplasty of the hip joint.
A follow-up with different radiopharmaceuticals. Eur J Nucl Med.
1976 Aug 12;1 (3):178 (Figures 1 and 2) with kind written permission
from Springer Science + Business Media B.V.
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loosening, the test yields a sensitivity and specificity of
95 and 82%, respectively [15].
PET images were also analysed for the pattern and dis-
tribution of 18F fluoride PET uptake and categorised into
three types. Type 1 uptake showed no significant 18F
fluoride uptake; type 2 uptake shows mild localised up-
take on the cup side or stem. Type 3 pattern of uptake
demonstrates significant uptake which extends through
more than half of the bone-implant interface [15]. In
type1 pattern, 96% of the cases were normal, 80% of type
2 pattern were due to aseptic loosening and 95% of type
3 pattern cases were due to infection [15]. The final
diagnosis of infection was obtained by a combination ofFigure 1 Uptake ratios in patients without complications over
the cup.microbiologic culture, histopathology and polymerase
chain reaction (PCR) analysis of bacterial DNA with two
different primer and probe sets, one specific for the de-
tection of methicillin-resistant staphylococcus and an-
other for broad-range detection by universal PCR that
targets a part of 16S rDNA gene, with increased sensitiv-
ity [15,20]. Many PCRs that detect the universal 16S
rRNA bacterial gene have problems with false-positive
results, with necrotic bacteria detected by PCRs [21].
The clinical importance of positive results in the absence
of other clinic-pathologic and radiological features of in-
fection is of uncertain significance, but specificity can be
improved by combining a universal PCR with subse-
quent bacterial sequencing [21].
Discussion
It is important to distinguish between infection and
loosening because the management of these conditions
is very different. There is no consensus on the use of im-
aging algorithms for the diagnosis of loosening and in-
fection. In general, radionuclide imaging techniques are
sensitive but non-specific for diagnosing loosening and
yield little anatomical detail. Furthermore, a number of
radionuclide studies are often performed sequentially to
improve diagnostic accuracy [22], further prolonging the
interval between the onset of symptoms and diagnosis
[23]. Sodium fluoride positron emission tomography
(18F-NaF-PET) is a promising tool with high sensitivity
and specificity in the assessment of joint replacements,
but it possibly will be of limited use before the ninth
post-surgical month when the uptake curve ratios reach
a nadir particularly in the acetabular component [14].
This can be overcome by routinely imaging ‘at risk’ pros-
thesis at 3-month intervals for the detection of abnormal
rates of decline in peri-prosthetic 18F-NaF uptake. The
downside of this method would be its relatively high cost
and high radiation dose [3], but with reduced scanning
times with PET-CT [24], this may become a more at-
tractive option. 18F-NaF-PET also avoids patient contam-
ination as well as infection risk to technicians which
may occur in labelled white cell studies. The added value
of the CT component in 18F-NaF PET-CT would include
the detection of anatomical lesions such as occult frac-
tures, aseptic loosening and osteolysis as well as guiding
intervention procedures [6].
Alternately, with fluorodeoxyglucose positron emis-
sion tomography (18F-FDG-PET), the most commonly
used PET isotope, arthroplasty induces non-specific
periprosthetic increased uptake which persists for sev-
eral years, even in patients without evidence of infec-
tion or loosening [25].This can easily be misinterpreted
as periprosthetic infection resulting in false positives
most notably in the head and neck portions of femoral
prostheses [25].
Adesanya et al. Journal of Orthopaedic Surgery and Research  (2015) 10:5 Page 5 of 5Conclusion
Serial or single sodium fluoride positron emission tom-
ography (18F-NaF-PET) is a sensitive and specific tool
for assessing joint prostheses. Furthermore, the CT com-
ponent enhances its diagnostic and radiological inter-
ventional value. Wider studies are required to identify
normal and pathological patterns in both hip and knee
prostheses.
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